| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50242-064-01 | 50242-064 | HUMAN PRESCRIPTION DRUG | TARCEVA | erlotinib hydrochloride | TABLET | ORAL | 20050430 | N/A | NDA | NDA021743 | Genentech, Inc. | ERLOTINIB HYDROCHLORIDE | 150 mg/1 | 30 TABLET in 1 BOTTLE (50242-064-01) |
| 50242-063-01 | 50242-063 | HUMAN PRESCRIPTION DRUG | TARCEVA | erlotinib hydrochloride | TABLET | ORAL | 20050430 | N/A | NDA | NDA021743 | Genentech, Inc. | ERLOTINIB HYDROCHLORIDE | 100 mg/1 | 30 TABLET in 1 BOTTLE (50242-063-01) |
| 50242-062-01 | 50242-062 | HUMAN PRESCRIPTION DRUG | TARCEVA | erlotinib hydrochloride | TABLET | ORAL | 20050430 | N/A | NDA | NDA021743 | Genentech, Inc. | ERLOTINIB HYDROCHLORIDE | 25 mg/1 | 30 TABLET in 1 BOTTLE (50242-062-01) |